Home � Products & Services � Benchmarking Reports � Medical Affairs � Launch Optimization

Building More Effective Medical Affairs Product Launch Teams: Immunology Segment

Download FREE Excerpt

ID: POP-388

Features:

12 Info Graphics

32 Data Graphics

660+ Metrics

19 Narratives

Pages: 56

Published: 2024

Delivery Format: Shipped

License Options:
$6000 - 1 user
$18000 - Up to 5 users
$30000 - Up to 20 users

Buy Now

919-403-0251

Schedule a Meeting

STUDY OVERVIEW
BENCHMARK CLASS
STUDY SNAPSHOT
KEY FINDINGS
VIEW TOC AND LIST OF EXHIBITS

In the dynamic field of immunology, Medical Affairs teams are central to orchestrating successful product launches, navigating the complex interplay between complex disease states, innovative treatments and patient needs. In many ways, Medical Affairs groups have become a key differentiator in this high-growth and highly competitive therapeutic space.

Best Practices, LLC undertook this benchmarking research to investigate the role of Medical Affairs in immunology product launches. The report investigates their evolving responsibilities, cross-functional alignment, effective activities, performance measurement, strategic resourcing, and digital utilization within the immunology therapeutic area. The report also identifies the key factors for success and the unique challenges that must be overcome for effective launch preparedness.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Academic; Research; Biotech; Chemical; Consulting; Consumer Products; Health Care; Medical Device; Science

Companies Profiled:
AstraZeneca; ASC Therapeutics; Boehringer Ingelheim; Duke University and Health System; EMD Serono; Genentech; GlaxoSmithKline ; Gr�nenthal; Helsinn; MEDiSTRAVA; Novartis; Pfizer; Pixacore; Takeda Pharmaceuticals; Terumo BCT: Terumo Blood and Cell Technologies; Thermo Fisher Scientific

Study Snapshot

Best Practices, LLC engaged 23 Medical leaders from 16 leading life sciences companies in this benchmarking research study. Medical Directors and upper management executives represent nearly four-fifths of the leaders who shared data and insights on Medical launch activities in this study.

Key topics covered in this report include:

Medical Leadership Roles and Launch Activity Effectiveness in Immunology
Ensuring Cross-functional Alignment and Collaboration in Immunology Launches
Medical Launch Evolution in Immunology Segment
Immunology Launch Activities Timeline, Performance Tracking, and Resourcing
Critical Success Factors and Major Pitfalls for Medical Affairs During Immunology Launches
Digital Launch Implementation and Impact in Immunology
Launch Tool Deployment for Immunology Products

Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.

Launch Tool Deployment: Immunology benchmark participants typically kick off digital activities one phase later than when they should ideally start, according to their own standards. The widest gap occurs in actual Medical Regulatory engagement time vs. ideal.

Table of Contents

Sr. No.	Topic	Slide No.
I.	Executive Summary	Pg. 4
II.	Section I: Launch Excellence and Medical’s Role & Activity Effectiveness	Pg. 6-12
III.	Section II: Ensuring Cross-functional Alignment and Collaboration	Pg. 13-15
IV.	Section III: Adopting to Ongoing Changes in Medical Landscape	Pg. 16-20
V.	Section IV: Launch Timeline, Preparedness Metrics, and Resourcing	Pg. 21-26
VI.	Section V: Critical Success Factors and Major Pitfalls	Pg. 27-32
VII.	Section VI: Digital Influence on Launch Processes and Launch Tool Deployment	Pg. 33-41
VIII.	Section VII: Participant Demographics	Pg. 42-43
IX.	Section VIII: Detailed Benchmark Study Data	Pg. 44-55
X.	Section IX: About Best Practices, LLC	Pg. 56

List of Charts & Exhibits

I. Launch Excellence and Medical’s Role & Activity Effectiveness

Medical launch excellence framework
Medical Affairs’ role in immunology launches
Medical leadership roles in immunology launches
Medical Affairs’ effectiveness in immunology launch activities
Most effective launch activities for Medical Affairs in immunology
Improvement opportunities for Medical Affairs around immunology launch activities

II. Ensuring Cross-functional Alignment and Collaboration

Medical Affairs’ work with internal colleagues to ensure successful immunology launches
Role of Medical Affairs group in cross-functional immunology launch teams

III. Adopting to Ongoing Changes in Medical Landscape

Change fronts for Medical launch evolution
Medical Affairs’ launch evolution around digital data dissemination and communication
Medical Affairs’ launch evolution around medical education
Medical Affairs’ launch evolution around organizational support

IV. Launch Timeline, Preparedness Metrics and Resourcing

Medical Affairs’ immunology launch activities timeline
Total annual Medical Affairs launch investment in U.S. dollars and number of FTEs for immunology products during each of the years in launch phase
Launch dashboard and information used with the dashboard for immunology
Percentage of total Medical Affairs launch investment allocated to each of the listed Medical Affairs activities in immunology
Percentage of total Medical Affairs launch FTEs allocated to each of the listed Medical Affairs activities in immunology

V. Critical Success Factors and Major Pitfalls

Critical success factors for Medical Affairs in immunology launches
Areas where advanced team planning is key for immunology launches
Six priority areas for successful Medical Affairs launch readiness in immunology
Major pitfalls for Medical Affairs during immunology launches
Six major challenge areas for Medical Affairs during immunology launches

VI. Digital Influence on Launch Processes and Launch Tool Deployment

Post-pandemic digital technology utilization in Medical Affairs during immunology product launches
Impact of digital technologies on current and future immunology launch processes
Digital launch tool deployment and impact
Impact of top three digital activities that Medical leads in immunology
Impact of digital activities and programs used to support a successful immunology product launch
Top digital tools that can bring success to Medical Affairs product launch activities
Fast-growing digital tools that are impacting Medicals’ launch strategy
Example of a valuable digital tool that supports launch activities

VII. Participant Demographics

Geographic responsibility of benchmark partners

VIII. Detailed Benchmark Study Data

Role served by Medical Affairs in immunology product launches
Medical Affairs’ launch role effectiveness in immunology
Role served by Medical Affairs in planning, research, and education activities in immunology segment
Role served by Medical Affairs in data dissemination and organizational support activities in immunology segment
Role served by Medical Affairs in research activities in immunology segment
Role served by Medical Affairs in education and data dissemination support activities in immunology segment
Role served by Medical Affairs in organizational support activities in immunology segment
Medical Affairs launch activity involvement timeline - Evidence generation and field-based medical activities in immunology
Medical Affairs launch activity involvement timeline - Medical information and medical regulatory activities in immunology
Medical Affairs launch activity involvement timeline - HEOR activities and medical / scientific communications in immunology
Medical Affairs launch activity involvement timeline - Independent medical education and external engagement activities in immunology